Menopausal Age, Type Not Related to Cardiovascular Risk Factors Later in Life
The age at and cause of period cessation were not found to be associated with conventional cardiovascular risk factors across middle age and later life.
Hormone Replacement Therapy
First Testosterone Undecanoate Softgel Approved by FDA for Hypogonadism
Jatenzo® (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism.
ACP Issues Guidelines for Use of Testosterone Therapy in Age-Related Low Testosterone
The American College of Physicians has issued a set of recommendations to clarify the potential benefits and harms of testosterone therapy in men with age-related low testosterone.
Breast Cancer Rates Differ With Use of Estrogen Alone vs Estrogen Plus Progestin
For postmenopausal women, conjugated equine estrogen alone is associated with a long-term decrease in breast cancer incidence, while CEE plus medroxyprogesterone acetate is associated with increased incidence.
Waist Circumference Affects Coronary Plaque Accumulation in Testosterone Therapy
Older men receiving testosterone treatment with higher waist-to-hip ratio experience greater increases in noncalcified coronary plaque volume.
Testosterone Replacement May Improve Body Composition in Male Cancer Survivors
Testosterone replacement therapy may improve body composition in young male cancer survivors with borderline-low testosterone levels.
Short-Term Testosterone Therapy Associated With VTE Risk in Men
For men with and without hypogonadism, testosterone therapy is associated with an increased short-term risk for venous thromboembolism.
Extended Estrogen Therapy Aids Late-Life Cognition
Longer use of estrogen hormone therapy is associated with higher cognitive status in late life.
Inaccuracies of Weight-Based Levothyroxine Dosing After Total Thyroidectomy
In patients with overweight or obesity who undergo total thyroidectomy, choosing the thyroid hormone replacement dose based on body weight is frequently inaccurate and could be responsible for prolongation of the titration period.
Effects of Estrogen-Only Treatment in Women With Prior Hysterectomy
For women aged 50 to 59 years with a history of bilateral oophorectomy, estrogen therapy may have beneficial effects in the long-term.
Next post in Androgen and Reproductive Disorders
